Partnership for Health System Sustainability and Resilience (PHSSR)
Use a maximum of two downloads here
Home / Sustainability / Health systems resilience / Partnership for Health System Sustainability and Resilience (PHSSR)
The rising burden of chronic disease and the impacts of climate change, mean that health systems are struggling to meet people’s health needs. And around the world, inequities in healthcare are growing from low- to high-income countries, with vulnerable populations the most affected.
To address these challenges, we need to prioritise building stable, resilient health systems with the right infrastructure, to deliver equitable outcomes and meet people’s health needs today and tomorrow.
We co-founded the Partnership for Health System Sustainability and Resilience (PHSSR) with the London School of Economics and the World Economic Forum to drive policy change that strengthens health systems globally. Through this non-profit, multi-sector, global collaboration, we're working across more than 36 countries to build sustainable and resilient health systems. This public-private partnership has published over 30 reports, engaged more than 100 policymakers, and catalysed policy changes to enhance care for millions of patients.
The PHSSR is taking a cross-border and cross-sectoral approach to accelerate change in our health systems, based on research, evidence-driven recommendations for change, and a focus on driving health system transformation. Since launch, the partnership has expanded to include members such as Philips, the Center for Asia-Pacific Resilience and Innovation (CAPRI), and the World Health Organization Foundation (WHO Foundation), alongside regional and national organisations.
We can act today and prepare for the future. We must look beyond the immediate and prioritise long-term action on health. Early detection and prevention can reduce the burden of chronic diseases while strengthening health system resilience. In practice, this requires more than dialogue - it demands genuine collaboration and joint ownership across sectors to deliver better, longer and healthier lives for all.
Taking bold action for a sustainable future
We support PHSSR's global goals by providing tools and resources for research and collaboration, facilitating knowledge sharing and helping build platforms for implementing multi-sector policies globally.
As an official partner at World EXPO 2025 in Osaka, we co-hosted a PHSSR Summit to advance health system transformation in Japan – home to the world's fastest-ageing and a rising non-communicable disease (NCD) burden. The Summit convened over 100 policymakers, academics, and government representatives to introduce Japan's PHSSR Policy Roadmap.
In January 2026, PHSSR launched a White Paper at the World Economic Forum presenting research from eight countries on how health systems can detect and treat chronic diseases earlier. National chapters will be published in each country to guide local policy change.
Through these collective efforts, we're strengthening health systems to improve care and treatment for millions of patients.
36+
27+
100+
Our global impact
UAE
Through collaboration with the UAE Department of Health and other key stakeholders, Chronic kidney disease (CKD) screening has been expanded to over 375,000 people, with early intervention expected to cut CO2e emissions by reducing the need for more resource-intensive forms of care.
The collaboration with the Ministry of Health has also led to major advancements in lung cancer detection, from its inclusion in the National Cancer Control Plan, to the delivery of 210,000 AI-enabled scans, and creation of national screening guidelines.
These initiatives demonstrate a commitment to strengthening health system resilience and reducing environmental impact through early detection and integrated care
Brazil
Brazil's Unified Health System has faced chronic underfunding, restricting access to early detection services, particularly for lung cancer.
A study investigating alternative financing models showed that earmarking dedicated revenue streams for lung cancer care screening, treatment and smoking prevention is both technically sound and politically feasible. Key study recommendations include expanding screening and treatment guidelines, strengthening primary care for early detection, and establishing governance to ensure funds reach frontline services.
We’re participating in cross-sector discussions on how to sustainably finance lung cancer screening in Brazil, aiming to improve early detection outcomes and reduce late-stage diagnoses.
Egypt
We supported efforts to establish rare diseases as a national priority through PHSSR, culminating in Egypt’s leadership on the WHA Rare Diseases resolution. PHSSR economic data demonstrated that planned funding is more efficient than ad hoc payments, enableing the Ministry of Health to create a sustainable financing model and establish a $200 million rare diseases fund.
A unified multicriteria decision analysis (MCDA) scorecard was developed to standardise treatment decisions, with 12 therapy areas prioritised. This has led to faster diagnosis, reduced from approximately 60 to 10 days, and improved coverage predictability for patients.
Future impacts expected in 2026 include a National Rare Diseases Action Plan, a new patient advocacy alliance, an accelerated pediatric patient referral pathway, and the integration of rare diseases into medical education.
Greece
In Greece, where an estimated 80% of people with CKD remain undiagnosed, PHSSR recommendations are helping to close the diagnostic gap, improve timely referrals, strengthen health system resilience, and advance health equity nationwide.
Evidence on the benefits of early detection – such a including automatic kidney function calculations in lab results – enabled the Ministry of Health to elevate CKD alongside cancer and cardiovascular disease on the national prevention agenda, and launch a screening program using the e-prescription platform to send SMS invitations for free diagnostic tests to high-risk citizens.
Vietnam
Through the PHSSR, we partnered with Vietnamese Ministry of Health and the Health Strategy and Policy Institute to advance fiscal, service delivery, and primary care preparedness policy reforms.
Funding mechanisms have been strengthened through National Health Technology Assessment capabilities, oncology reimbursement policies improved, and access to innovative medicines enhanced. Service delivery has also been transformed by shifting NCD care towards integrated, community-based approaches such as the CaReMe (Cardiovascular - Renal - Metabolic) programme and the Units for Management of Asthma and COPD network.
Veeva ID: Z4-82737
Date of preparation: April 2026